Todos and Amarantus Announce Completion of LymPro PET 1 Study by Leipzig University for Alzheimer’s Blood Diagnostic LymPro Test 2.0

REHOVOT, Israel and NEW YORK, April 08, 2019 (GLOBE NEWSWIRE) — Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics

Read more

International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury

CARLSBAD, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based

Read more

PROCESSA PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN CLINICAL TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF PCS-499 FOR THE TREATMENT OF NECROBIOSIS LIPOIDICA

HANOVER, MD, Jan. 29, 2019 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (OTCQB: PCSA), a clinical stage biopharmaceutical company developing products

Read more

YIELD GROWTH Announces Completion of FDA Compliant Evaluation with Human Subjects to Establish an SPF Factor of 31 for Urban Juve’s Sunscreen Formula

VANCOUVER, British Columbia, Jan. 28, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) (C:BOSS) (OTC:BOSQF) (Frankfort: YG3) announces completion of the

Read more

Cannabics Pharmaceuticals and NewCanna Hub Intend to Collaborate to Manufacture and Market Cannabics’ SR Capsules in Colombia

TEL AVIV, Israel and BETHESDA, Maryland, Jan. 24, 2019 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its

Read more